BAP1 and prostate adenocarcinoma: Based on high (H) or low (L) BAP1 gene expression levels, we investigated the survival difference within these two groups and found that in LGG, HNSC and PRAD, the survival difference between BAP1 high- and low- expression patients was slightly significant (–log­10 (p-value) >1.2) (Figure 4A, B).